Deferasirox Tablet, Film Coated
Product Images NDC 59651-412

Product Visual Gallery

This gallery contains 5 technical images submitted to the FDA as part of the official labeling for Deferasirox (NDC 59651-412). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Aurobindo Pharma Limited, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Fig1 (Deferasirox Fig1)

FDA Label Image

Package Label-principal Display Panel (90 mg (30 Tablet Bottle))

FDA Label Image

Package Label-principal Display Panel (180 mg (30 Tablet Bottle))

Deferasirox Tablets are available in a pack of 30 tablets, each containing 180 mg of Deferasirox. The usual dosage should be followed as mentioned in the package insert. It is important to keep this medication and all drugs out of the reach of children. The tablets should be stored at a temperature of 20°C to 25°C (68°F to 77°F) and protected from moisture. A Medication Guide should be printed for each patient, which can be found at www.aurobindousa.com/medication-guides. The tablets are distributed by Aurobindo Pharma USA, Inc. and manufactured in India.*

FDA Label Image

Package Label-principal Display Panel (360 mg (30 Tablet Bottle))

FDA Label Image

Chemical Structure (Deferasirox Str)

* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.